Real-Time Continuous Glucose Monitoring Reduced Costly Diabetes-Related Events in Adolescents and Young Adults despite Lack of Short-Term Reduction in Hemoglobin A1c
Table 4
Glycemic outcomes at 24 weeks.
TAU
Intervention
t-test
value
Cohen’s d
N = 131
N = 191+
Time rtCGM active (%)
95.08 ± 5.16
89.72 ± 14.49
1.482
0.151
0.459
Time in range 70–180 mg/dL (%)
33.42 ± 19.73
25.30 ± 20.63
1.241
0.224
0.447
Mean glucose (mg/dL)
231.00 ± 56.05
263.21 ± 71.03
−1.367
0.182
−0.492
Coefficient of variation
33.21 ± 9.55
30.77 ± 10.37
0.674
0.505
0.243
Hypoglycemia
Time with glucose 54–69 mg/dL (%)
0.65 ± 0.96
0.56 ± 0.74
0.294
0.771
0.106
Time with glucose <54 mg/dL (%)
1.05 ± 2.96
0.07 ± 0.21
1.192
0.256
0.522
Hyperglycemia
Time with glucose 181–250 mg/dL (%)
29.95 ± 17.00
19.89 ± 12.09
1.989
0.056
0.709
Time with glucose >250 mg/dL (%)
39.41 ± 24.72
53.14 ± 29.13
−1.390
0.175
−0.500
1Mean ± standard deviation. +One participant was excluded from this data due to missing rtCGM data at the 24-week study visit. rtCGM = real-time continuous glucose monitoring. Note. Data collection period includes the 2 weeks prior to the 24 week study visit. Equal variances not assumed.
